Skin Diseases, Papulosquamous  >>  AMG 811  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AMG 811 / Amgen
NCT01510951: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

Completed
1
9
RoW
AMG 811 or Placebo
Amgen
Psoriasis
10/12
10/12

Download Options